Life Science LeaderANAVEX® Life Sciences Corp.Jul 31, 20151 min readAlzheimer’s Drug Development: Not An Easy Path To Pursue
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
